RxDoctor Payments Data

Kelly Presnell

Nurse Practitioner · Layton, UTNPI 1386183838

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,527 and has fallen 98.7% since, to $19 in 2024. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,372in general payments, 2019–2025

Across 328 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$686
  • Novo Nordisk$542
  • Dexcom, Inc.$471
  • Lilly USA, LLC$401
  • Xeris Pharmaceuticals, Inc.$291
  • Tandem Diabetes Care, Inc.$275
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$4,372100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,372 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$33,283
TrulicityDulaglutide21$21,101
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$8,656
Novolog FlexpenInsulin Aspart11$2,987
Levothyroxine Sodium30$260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$401$21,10121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →